PharmaFluidics gets top investors on board
The biotech investors Rudi Mariën en Annie Vereecken invest money in VUB spin-off PharmaFluidics, following a capital round of more than €7 million. Mariën is seen as the uncrowned king of biotech. Vereecken, just like Mariën a pharmacist, became a great entrepreneur and invests a lot in biotech.
Click here to read the article in De Tijd.